Astellas Pharma Inc (ALPMY)

$9.34 -0.39 (-4.01%)
Market Cap 17.48B
Revenue (ttm) 10.62B
Net Income (ttm) 113.00M
EPS (ttm) N/A
PE Ratio 12.38
Forward PE 25.88
Profit Margin 1.06%
Debt to Equity Ratio 0.61
Volume 81,400
Avg Vol 160,220
Day's Range N/A - N/A
Shares Out 1.81B
Stochastic %K 5%
Beta 0.29
Analysts Sell
Price Target $11.30

Latest News on ALPMY

No data available.